Tenaya Therapeutics
IPO
Scaling new heights in the fight against heart disease
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- tenayatherapeutics.com
- Total Funding
- $106.0M
- Last Round
- $106.0M Series CMar 2021
About
Tenaya Therapeutics is a clinical-stage biotechnology company founded by leading cardiovascular scientists to discover, design, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. The company focuses on gene therapy and cellular reprogramming approaches to change the treatment paradigm for patients with serious cardiac conditions.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account